🔎 Trials Near Me

Início › Câncer de Pulmão › Alabama

Ensaios clínicos de Câncer de Pulmão em Alabama

16 estudos para Câncer de Pulmão estão buscando participantes em locais em Alabama.

Cidades em Alabama

Texto oficial do estudo (Inglês)

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

  • Alabama Oncology, Birmingham
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT06881784

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

  • Clearview Cancer Institute (Crestwood), Huntsville
  • Clearview Cancer Institute, Huntsville
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07489066

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • University of Alabama at Birmingham, Birmingham
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07154290

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

  • University of Alabama at Birmingham, Birmingham
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT06618287

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

  • Birmingham Hematology and Oncology Associates LLC d/b/a Alabama Oncology, Birmingham
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06712316

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • University of Alabama Birmingham, Birmingham
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 10 de set. de 2026 · NCT06293898

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Clearview Cancer Institute, Huntsville
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06119581

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

  • O'Neal Comprehensive Cancer Center at UAB, Birmingham
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06343402

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

  • University of Alabama at Birmingham Cancer Center, Birmingham
  • The Kirklin Clinic at Acton Road, Birmingham
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne
  • e mais 3
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT05624996

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne
  • Thomas Hospital, Fairhope
  • Mobile Infirmary Medical Center, Mobile
  • e mais 1
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 3 de jun. de 2026 · NCT05642572

MYLUNG Consortium Part 3: Observational Study

  • Southern Cancer Center, PC, Daphne
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 18 de mai. de 2026 · NCT05885698

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne
  • Thomas Hospital, Fairhope
  • Mobile Infirmary Medical Center, Mobile
  • e mais 1
RecrutandoFase 2
18 Minutes · Todos os sexos · Atualizado em 5 de mai. de 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis, Daphne
  • Thomas Hospital, Fairhope
  • Mobile Infirmary Medical Center, Mobile
  • e mais 1
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 5 de mai. de 2026 · NCT06616584

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

  • University of Alabama at Birmingham, Birmingham
  • University of South Alabama, Mobile
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 30 de abr. de 2026 · NCT05297734

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Birmingham
  • Massive Bio SYNERGY-AI site, Mobile
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774

A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

  • XCancer Research Network/Dothan Hematology & Oncology, Dothan
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 24 de out. de 2025 · NCT06228326

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.